Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Abstract Cancer vaccines hold great potential for clinical cancer treatment by eliciting T cell‐mediated immunity. However, the limited numbers of antigen‐presenting cells (APCs) at the injection sites, the insufficient tumor antigen phagocytosis by APCs, and the presence of a strong tumor immunosup...

Full description

Bibliographic Details
Main Authors: Zhaoxia Chen, Tuying Yong, Zhaohan Wei, Xiaoqiong Zhang, Xin Li, Jiaqi Qin, Jianye Li, Jun Hu, Xiangliang Yang, Lu Gan
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202305081